Impact of adherence to statins on cardiovascular adverse events in patients with coronary artery disease: a meta-analysis

被引：0
|
作者：
李淑婷 [1 ]
机构：
[1] Dept Cardiol,1st Affil Hosp,Dalian Med Univ
来源：
China Medical Abstracts (Internal Medicine) | 2016年 / 33卷 / 04期
关键词：
in; CAD; PDC; were; a meta-analysis; Impact of adherence to statins on cardiovascular adverse events in patients with coronary artery disease; of; on; with;
D O I：
暂无
中图分类号：
R543.3 [冠状动、静脉疾病];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To evaluate the impact of different adherence mode to statins on cardiovascular adverse events in patients with coronary artery disease(CAD).Methods Electronic searches,including Pub Med,Scopus,Ovid MEDLINE,Ovid EMBASE,Ovid EBM Reviews CENTRAL,CINAHL,The Cochrane Library,Ovid Psyc Info,
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [21] The prognostic impact of the coronary collateral circulation in patients with coronary artery disease: A meta-analysis
    Zhu, Huizheng
    Liang, Yudan
    Zuo, Tian
    Zhang, Minzhou
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 : S158 - S166
  • [22] Coronary artery calcium score and risk of cardiovascular events without established coronary artery disease: a systemic review and meta-analysis
    Abuzaid, Ahmed
    Saad, Marwan
    Addoumieh, Antoine
    Ha, Le Dung
    Elbadawi, Ayman
    Mahmoud, Ahmed N.
    Elgendy, Akram
    Abdelaziz, Hesham K.
    Barakat, Amr F.
    Mentias, Amgad
    Adeola, Oluwaseun
    Elgendy, Islam Y.
    Qasim, Atif
    Budoff, Matthew
    CORONARY ARTERY DISEASE, 2021, 32 (04) : 317 - 328
  • [23] Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis
    Wang, Zhi Jian
    Zhou, Yu Jie
    Galper, Benjamin Z.
    Gao, Fei
    Yeh, Robert W.
    Mauri, Laura
    HEART, 2015, 101 (20) : 1631 - 1638
  • [24] Meta-analysis of clinical adverse events after CABG vs. PCI in patients with chronic kidney disease and coronary artery disease
    Luo, Cheng
    Wang, Qiang
    Nong, Shuxiong
    Chen, Yushan
    Li, Longchang
    Gui, Chun
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [25] Meta-analysis of clinical adverse events after CABG vs. PCI in patients with chronic kidney disease and coronary artery disease
    Cheng Luo
    Qiang wang
    Shuxiong Nong
    Yushan Chen
    Longchang Li
    Chun Gui
    BMC Cardiovascular Disorders, 23
  • [26] Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease
    Berger, Ariel
    Simpson, Alex
    Bhagnani, Tarun
    Leeper, Nicholas J.
    Murphy, Brian
    Nordstrom, Beth
    Ting, Windsor
    Zhao, Qi
    Berger, Jeffrey S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (12): : 1893 - 1899
  • [27] Plasma triglycerides and cardiovascular events in the TNT and IDEAL trials of statins in patients with coronary artery disease
    Faergeman, O.
    Holme, I.
    Larosa, J. C.
    Waters, D. D.
    Olsson, A. G.
    Fayyad, R.
    Kastelein, J. J. P.
    EUROPEAN HEART JOURNAL, 2008, 29 : 346 - 346
  • [28] Effect of Statins on Clinical Outcomes in Patients With Coronary Artery Spasm: A Meta-Analysis
    Liu, Qilin
    Zhang, Yanbin
    Du, Dayong
    Yang, Liu
    Lu, Huaizhi
    Tao, Zhang
    Miao, Yang
    Yi, Xue
    Li, Yuntian
    CLINICAL THERAPEUTICS, 2022, 44 (07) : 971 - 981
  • [29] Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease
    von Haehling, Stephan
    Papassotiriou, Jana
    Morgenthaler, Nils G.
    Hartmann, Oliver
    Doehner, Wolfram
    Stellos, Konstantinos
    Wurster, Thomas
    Schuster, Andreas
    Nagel, Eike
    Gawaz, Meinrad
    Bigalke, Boris
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 162 (01) : 27 - 32
  • [30] Rivaroxaban for the prevention of major adverse cardiovascular events in patients with coronary or peripheral artery disease
    Wheeler, Matt
    Chan, Noel
    Eikelboom, John
    FUTURE CARDIOLOGY, 2020, 16 (06) : 597 - 612
12345